
Kern Pharma mulls new acquisitions
Catalan Economy
26 Jun 2009
Kern pharma, a unit of pharmaceutical group indukern, has announced that it is looking into new acquisitions to grow in catalonia and strengthen its presence in international markets. indukern ceo raul diaz-varela confirmed that its company is interested in acquiring the solvay pharma plant in parets del vallès or one of labiana factories. kern facilities in terrassa could reach its maximum production capacity in less than two years, he added. the group is also studying acquisitions in france and italy to strengthen its european business. in 2008, indukern posted revenue of 550 million euros, up 7.8% over the previous year.
source: expansión catalunya 25/06/09
More news and success stories.
-
05 May 2023
Catalonia is the second European region attracting funding for Deep Tech startups
-
02 May 2023
Catalonia's health startup ecosystem has increased investments by 87%, defying the global decline trend
-
27 Apr 2023
Barcelona will host Berry's new global center of excellence and circular innovation
-
25 Apr 2023
Barcelona will host LGT's digital development hub